Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAdaptimmune Therapeutics PLC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Adaptimmune Therapeutics PLC

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 2, 2025Wood GavinChief Financial Officer96,000Ordinary Shares with a nominal value of GBP0.001 per share—Sell
Aug 28, 2025Bertrand William C JRChief Operating Officer207,000Ordinary Shares with a nominal value of GBP0.001 per share—Sell
Aug 18, 2025Behbahani AliDirector14,671,794Ordinary Shares with a nominal value of 0.001 GBP per share—Sell
Aug 15, 2025Behbahani AliDirector4,828,206Ordinary Shares with a nominal value of 0.001 GBP per share—Sell
Jul 30, 2025EcoR1 Capital, LLC10% Owner27,433,338Ordinary Shares—Sell
Jul 29, 2025EcoR1 Capital, LLC10% Owner2,687,460Ordinary Shares—Sell
Jul 28, 2025EcoR1 Capital, LLC10% Owner33,931,740Ordinary Shares—Sell
Feb 20, 2025Rawcliffe AdrianChief Executive Officer3,428,832Option to purchase Ordinary Shares—Grant / award
Feb 20, 2025Rawcliffe AdrianChief Executive Officer5,143,248Option to purchase Ordinary Shares—Grant / award
Feb 20, 2025Norry ElliotChief Medical Officer1,074,696Option to purchase Ordinary Shares—Grant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$0.02Close · Oct 6, 2026